Acute myeloid leukemia (AML) is an extremely heterogeneous disease defined by the clonal
growth of myeloblasts/promyelocytes not only in the bone marrow but also in peripheral …

An important direction of research in increasing the effectiveness of cancer therapies is the
design of effective drug distribution systems in the body. The development of the new …

Nucleoside-based drugs, recognized as purine or pyrimidine analogs, have been potent
therapeutic agents since their introduction in 1950, deployed widely in the treatment of …

Drug delivery systems based on ring-like nanocarriers such as 2-hydroxypropyl-β-
cyclodextrin (HP-β-CD) and genipin-crosslinked chitosan (GCS) are increasingly used in the …

Porous CI codoped carbon nitride materials were synthesized by in-situ codoping with
iodized ionic liquid followed by post-thermal treatment in air. The effects of doping content of …

Background Acute myeloid leukemia (AML) is an aggressive hematological cancer resulting
from uncontrolled proliferation of differentiation-blocked myeloid cells. Seventy percent of …

Most anticancer agents induce cancer cell death; however, multidrug‐resistant cancers often
lead to treatment failure. The effective use of curcumin as an anticancer agent has been …

Over half of older patients with acute myeloid leukemia (AML) do not respond to cytotoxic
chemotherapy, and most responders relapse because of drug resistance. Cytarabine is the …

Investigation into intracellular ribonucleotides (RNs) and deoxyribonucleotides (dRNs) is
important for studies of the mechanism of many biological processes, such as RNA and DNA …

Magnetotactic bacteria (MTBs) and their organelles, magnetosomes, are intriguing options
that might fulfill the criteria of using bacterial magnetosomes (BMs). The ferromagnetic …